<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02690389</url>
  </required_header>
  <id_info>
    <org_study_id>SiChuanCHRI001</org_study_id>
    <nct_id>NCT02690389</nct_id>
  </id_info>
  <brief_title>Electro-acupuncture and Flumazenil's Effect on Sedation</brief_title>
  <acronym>EA&amp;FLUM</acronym>
  <official_title>The Sedation Effect of Electro-acupuncture on Bilateral Zusanli (ST 36) and Neiguan (PC 6) in General Anesthesia May Not be Mediated by the Benzodiazepines- GABA Pathway</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Yin Liu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sichuan Cancer Hospital and Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sichuan Cancer Hospital and Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in
      general anaesthesia through investigating the role of the Benzodiazepines-GABA system.

      Method: 80 patients undergoing abdominal surgery were randomly divided into four groups
      (n=20): C group (propofol only group), F group (propofol + flumazenil group), EA group
      (propofol + electro-acupuncture group), and EA+F group (propofol + electro-acupuncture +
      flumazenil group). Before induction, acupuncture needles were inserted at the points of
      Zusanli (ST 36) and Neiguan (PC 6) bilaterally to elicit&quot;DeQi&quot;. Target-controlled infusion
      (TCI) of propofol was used for the induction and maintenance of anaesthesia. After 15minutes,
      equilibrium of Narcotrend Index (NT index) was achieved, patients were then assigned to
      receive different interventions. In EA group and EA+F group, patients received EA for 30
      minutes under general anaesthesia, and flumazenil with the dosage of 0.1mg/kg was added in
      the latter at the end of EA. In C group and F group, patients didn't receive EA, and
      flumazenil with the dosage of 0.1mg/kg was administered in F Group at the same time point
      with EA+F group. HR, MAP and NT index were recorded at different time points up to 30 minutes
      after the end of EA.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>depth of general anaesthesia</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Acupuncture</condition>
  <condition>General Anaesthesia</condition>
  <condition>Sedation</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard procedure is used</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flumazenil only group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>flumazenil is given</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control with acupuncture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>control with acupuncture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control with acupuncture and flumazenil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>control with acupuncture and flumazenil</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Flumazenil</intervention_name>
    <description>used alone or with acupuncture</description>
    <arm_group_label>Flumazenil only group</arm_group_label>
    <arm_group_label>control with acupuncture and flumazenil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>used alone or with flumazenil</description>
    <arm_group_label>control with acupuncture</arm_group_label>
    <arm_group_label>control with acupuncture and flumazenil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  80 abdominal surgical patients

          -  aged 30 to 60 years old,

          -  weighing 50-70Kg,

          -  ASA I-â…¡, who scheduled to receive general anaesthesia were enrolled to this trial.

        Exclusion Criteria:

          -  Hypertension or severe heart and lung diseases,

          -  Conditions that might affect the consciousness or NT index, such as seizures,
             psychosis, brain lesions, and treatment with sedative drugs,

          -  Contraindications to acupuncture, such as severe hemorrhagic disease, hyper-sensitive
             patient, and tumor or ulcer exist on the skin of the acupuncture points.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>yin liu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sichuan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sichuan Cancer Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2016</study_first_submitted>
  <study_first_submitted_qc>February 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2016</study_first_posted>
  <last_update_submitted>February 18, 2016</last_update_submitted>
  <last_update_submitted_qc>February 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Sichuan Cancer Hospital and Research Institute</investigator_affiliation>
    <investigator_full_name>Dr. Yin Liu</investigator_full_name>
    <investigator_title>Associate Professor, Chief of Clinical Research</investigator_title>
  </responsible_party>
  <keyword>Acupuncture</keyword>
  <keyword>Flumazenil</keyword>
  <keyword>Narcotrend</keyword>
  <keyword>General Anaesthesia</keyword>
  <keyword>Sedation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Flumazenil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will not be share until it is published</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

